Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

UPDATE: Rallybio Q3 Adj. EPS $(0.14) Beats $(0.21) Estimate, Sales $212.000K Beat $66.667K Estimate

Author: Benzinga Newsdesk | November 06, 2025 09:35am
Rallybio (NASDAQ:RLYB) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.21) by 34.58 percent. This is a 46.15 percent increase over losses of $(0.26) per share from the same period last year. The company reported quarterly sales of $212.000 thousand which beat the analyst consensus estimate of $66.667 thousand by 218.00 percent. This is a 29.10 percent decrease over sales of $299.000 thousand the same period last year.

Posted In: RLYB


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist